{"schema_version":"secwatch.filing_event.v1","accession":"0001722482-24-000014","form_type":"8-K","ticker":"AVTR","cik":"0001722482","company_name":"Avantor, Inc.","filed_at":"2024-02-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.253617+00:00","generated_at":"2026-06-06T02:28:42.661222+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Avantor Q4 revenue $1.72B, decline 4%; adjusted EPS $0.25; new segment structure disclosed","bullets":["Q4 net sales $1.72B, down 4.0% YoY; core organic decline 4.8%; Q4 GAAP EPS $0.15, adjusted EPS $0.25.","Full-year 2023 net sales $6.97B, down 7.3%; adjusted EBITDA $1.309B; free cash flow $723.6M.","Repaid ~$850M of debt in 2023; adjusted net leverage 3.9x.","New segment reporting effective Q1 2024: Laboratory Solutions ($4.74B revenue in 2023) and Bioscience Production ($2.23B revenue).","Recast segment data provided for 2021-2023; adjusted operating income for Bioscience Production $601.9M, Laboratory Solutions $668.3M in 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001722482-24-000014","json":"https://secwatch.observer/filing/0001722482-24-000014.json","markdown":"https://secwatch.observer/filing/0001722482-24-000014.md","text":"https://secwatch.observer/filing/0001722482-24-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1722482/000172248224000014/0001722482-24-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1722482/000172248224000014/avtr-20240214.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T02:28:42.661222+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4ffa27c49a859164abeec19b06b7a36f3152faa9","claim":"Avantor, Inc. reported the year ended December 31, 2023 results: revenue $6.97 billion, net income $321.1 million, EPS $0.47.","evidence_excerpt":"Full Year 2023 • Net sales of $6.97 billion, decrease of 7.3%; core organic decline of 5.2% • Net income of $321.1 million; Adjusted EBITDA of $1,309.1 million • Diluted GAAP EPS of $0.47; adjusted EPS of $1.06","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1722482/000172248224000014/0001722482-24-000014-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the year ended December 31, 2023"},{"label":"Revenue","value":"$6.97 billion"},{"label":"Net income","value":"$321.1 million"},{"label":"EPS","value":"$0.47"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"fd3bd7266374057545a5aa556261d573770e517d","claim":"Avantor, Inc. reported the quarter ended December 31, 2023 results: revenue $1.72 billion, net income $98.5 million, EPS $0.15.","evidence_excerpt":"Fourth Quarter 2023 • Net sales of $1.72 billion, decrease of 4.0%; core organic decline of 4.8% • Net income of $98.5 million; Adjusted EBITDA of $302.1 million • Diluted GAAP EPS of $0.15; adjusted EPS of $0.25","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1722482/000172248224000014/0001722482-24-000014-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended December 31, 2023"},{"label":"Revenue","value":"$1.72 billion"},{"label":"Net income","value":"$98.5 million"},{"label":"EPS","value":"$0.15"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}